• Most Popular
  • Most Shared

UPDATE 1-Genzyme CEO sells 200,000 of company's shares

Wed Nov 25, 2009 12:44pm EST

Stocks

   

Nov 25 (Reuters) - Biotechnology company Genzyme Corp's (GENZ.O) Chief Executive Henri Termeer sold 200,000 shares of the company for $50.47 apiece on Nov. 23, according to a regulatory filing.

Stocks  |  Regulatory News  |  Mergers & Acquisitions  |  Healthcare

In the filing with the Securities and Exchange Commission, Termeer said he sold the shares after exercising options on the same number of shares for $26.50 per share the same day.

Shares of the company were up 1 percent at $51.00 in midday trade Wednesday on Nasdaq. (Reporting by Shailesh Kuber in Bangalore; Editing by Ratul Ray Chaudhuri) ((shailesh.kuber@thomsonreuters.com; within U.S. +1 646 223 8780; outside U.S. +91 80 4135 5800; Reuters Messaging: shailesh.kuber.reuters.com@reuters.net))
Stocks
Regulatory News
Mergers & Acquisitions
Healthcare


More from Reuters

A protestor holds a picture of former President George Washington crying as several groups hold a "Kill the Bill" rally against President Barack Obama's health care legislation, on the west front of the U.S. Capitol in Washington, March 20, 2010. Credit: REUTERS/Jonathan Ernst

Nailing down the votes

Democrats are getting closer to the number of votes needed to pass Obama's overhaul of healthcare.  Full Article | Video 

Healthcare Reform
Photo editor May Naji during an embed with U.S. troops in Iraq. REUTERS/File

Witness from the hurt locker

For Reuters journalist May Naji, a Iraqi native, some things are impossible to forget even after she left home to work abroad.  Full Article 

World
A general view of the northern Italian coastal town of Portofino, June 15, 2007. Credit: Reuters/Dario Pignatelli

Top playgrounds of the rich

Want to vacation like CEOs and celebrities? A men's website has listed its top towns that border the magical Mediterranean.  Full Article 

Lifestyle